Effects of green tea on matrix metalloproteinases in streptozotocin-induced diabetic rats

Journal of Clinical Biochemistry and Nutrition

Volumn 37, Issue 3, 2005, Pages 77-85

  Kamiya, Yuki ^a   Iwai, Shinichi ^a   Nara, Keinosuke ^a   Okazaki, Masako ^a   Oguchi, Katsuji ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Diabetic rats; Green tea; Matrix metalloproteinases; RT PCR; Zymography

Indexed keywords

CATECHIN; GELATINASE A; GELATINASE B; GREEN TEA EXTRACT; HEMOGLOBIN A1C; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

AMINO ACID URINE LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HYPERGLYCEMIA; INGESTION; KIDNEY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; TEA; ZYMOGRAPHY;

ANIMALIA;

EID: 33645779028     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.37.77     Document Type: Article

References (43)

1. Nagase, H. and Woessner, J.F.: Matrix metalloproteinases. J. Biol. Chem., 274, 21491-21494, 1999.
2. Dollery, C.M., McEwan, J.R., and Henney, M.: Matrix metalloproteinases and cardiovascular disease. Circ. Res., 77, 863-868, 1995.
3. Galis, Z.S., Sukhova, G.K., Lark, M.W., and Libby, P.: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest., 94, 2493-2503, 1994.
4. Matrisian, L.M.: The matrix-degrading metalloproteinases. Bioessays, 14, 455-463, 1992.
5. Nagase, H. and Woessner, J. F.: Matrix metalloproteinases. J. Biol. Chem., 274, 21491-21494, 1999.
6. Schneider, D.J. and Sobel, B.E.: Determinants of coronary vascular disease in patients with type 2 diabetes mellitus and their therapeutic implications. Clin. Cardiol., 20, 433-440, 1997.
7. Ruderman, N.B. and Haudenschild, C.: Diabetes as an atherogenic factor. Prog. Cardiovasc. Dis., 26, 373-412, 1984.
8. Uemera, S., Matsushita, H., Li, W., Glassford, A.J., Asagami, T., Lee, K.H., Hrrison, D.G., and Tsao, P.S.: Diabetes mellitus enhances vascular matrix metalloproteinase activity. Role of oxidative stress. Circ. Res., 88, 1291-1298, 2001.
9. Balentine, D.A., Wiseman, S.A., and Boumens, L.C.M.: The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr., 37, 693-704, 1997.
10. Nakayama, M., Suzuki, K., Toda, M., Okubo, S., Hara, Y., and Shimamura, T.: Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res., 21, 289-299, 1993.
11. Dashwood, R.H., Xu, M., Hernaez, J.F., Hasaniya, N., Youn, K., and Razzuk, A.: Cancer chemopreventive mechanisms of tea against heterocyclic amine mutagens from cooked meat. Proc. Soc. Exp. Biol. Med., 220, 239-243, 1999.
12. Cao, Y. and Cao, R.: Angiogenesis inhibited by drinking tea. Nature, 398, 381, 1999.
13. Katiyar, S.K.: Skin photoprotection by green tea: antioxidant and immunomodulatory effects. Curr. Drug Targets Immune. Endocr. Metabol. Disord., 3: 234-242, 2003.
14. Eckert, R.L., Crish, J.F., Efimova, T., and Balasubramanian, S.: Antioxidants regulate normal human keratinocyte differentiation. Biochem. Pharmacol., 68, 1125-1131, 2004.
15. Tijburg, L.B.M., Mattern, T., Folts, J.D., Weisgerber, U.M., and Katan, M.B.: Tea flavonids and cardiovascular diseases. Clit. Rev. Food Sci., 37, 711-785, 1997.
16. Demeule, M., Brossard, M., Page, M., Gingras, D., and Beliveau, R.: Matrix metalloproteinase inhibition by green tea catechins. Biochem. Biophys. Acta, 1478, 51-60, 2000.
17. Garbisa, S., Sartor, L., Biggin, S., Salvato, B., Benelli, R., and Albini, A.: Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer, 91, 822-832, 2001.
18. Song, E.K., Hur, H., and Han, M.K.: Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice. Arch. Pharm. Res., 26, 559-563, 2003.
19. Minami, M., Hasebe, Y., Nakanishi-Ueda, T., Iwai, S., Ueda, T., Dorey, C.K., Oguchi, K., Yasuhara, H., and Koide, R.: Inhibition of oxygen-induced retinal neovascularization in the neonatal rat by green tea extract. J. Clin. Biochem. Nutr., 33, 23-31, 2003.
20. Iwai, S., Okazaki, M., Kiuchi, Y., and Oguchi, K.: Changes in mRNA levels of fibrinogen subunit polypeptides in rats defibrinogenated with batroxobin. Thromb. Res., 96, 421-426, 1999.
21. Ma, D.H.K., Chen, J.K., Kim, W.S., Hao, Y.X., Wu, H.C., Tsai, R.J.F., Hwang, D.G., and Zhang, F.: Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization. Ophthalmic Res., 33, 353-362, 2000.
22. Phillips, P.A., McCarroll, J.A., Park, S., Wu, M.J., Pirola, R., Korsten, M., Wilson, J.S., and Apte, M.V.: Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover. Gut, 52, 275-282, 2003.
23. Fujisawa, T., Hattori, T., Takahashi, K., Kuboki, T., Yamashita, A., and Takigawa, M.: Cyclic mechanical stress induces extracellular matrix degradation in cultured chondrocytes via gene expression of matrix metalloproteinases and interleukin-1. J. Biochem., 125, 966-975, 1999.
24. Kao, Y.H., Hiipakka, R.A., and Liao, S.: Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology, 141, 980-987, 2000.
25. Waltner-Law, M.E., Wang, X.L., Law, B.K., Hall, R.K., Nawano, M., and Granner, D.K.: Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J. Biol. Chem., 277, 34933-34940, 2002.
26. Old, T., Matsui, T., and Osajima, Y.: Inhibitory effect of α-glucosidase inhibitors varies according to its origin. J. Agric. Food Chem., 47, 550-553, 1999.
27. Wada, M., Takita, T., and Innami, S.: Some kinds of teas suppress a sideration of diabetes in streptozotocin-administered rats. J. Clin. Biochem. Nutr., 20, 61-69, 1996.
28. Kim, M.J., Ryu, G.R., Chung, J.S., Sim, S.S., Min, D.S., Rhie, D.J., Yoon, S.H., Hahn, S.J., Kim, M.S., and Jo, Y.H.: Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro. Pancreas, 26, 292-299, 2003.
29. Chan, M.M., Fong, D., Ho, C.T., and Huang, H.I.: Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem. Pharmacol., 54, 1281-1286, 1997.
30. Chen, L., Lee, M.J., Li, H., and Yang, C.S.: Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab. Dispos., 25, 1045-1050, 1997.
31. Steffes, M.W., Osterby, R., Chavers, B., and Mauer, S.M.: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes, 38, 1077-1081, 1989.
32. Osterby, R., Parving, H.H., Hommel, E., Jorgensen, H.E., and Lokkegaard, H.: Glomerular structure and function in diabetic nephropathy. Early to advanced stages. Diabetes, 39, 1057-1063, 1990.
33. Drumond, M.C., Kristal, B., Myers, B.D., and Deen, W.M.: Structural basis for reduced glomerular filtration capacity in nephrotic humans. J. Clin. Invest., 94, 1187-1195, 1994.
34. Pugliese, G., Pricci, F., Pugliese, F., Mene, P., Lenti, L., Andreani, D., Galli, G., Casini, A., Bianchi, S., Rotella, C.M., and Di Mario, U.: Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes, 43, 478-490, 1994.
35. Sharma, K. and Ziyadeh, F.N.: Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes, 44, 1139-1146, 1995.
36. McLennan, S.V., Kelly, D.J., Cox, A.J., Cao, Z., Lyons, J.G., Yue, D.K., and Gilbert, R.E.: Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia, 45, 268-275, 2002.
37. McLennan, S.V., Fisher, E., Martell, S.Y., Death, A.K., Williams, P.F., Lyons, J.G., and Yue, D.K.: Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy. Kidney Int. Suppl., 77, S81-S87, 2000.
38. Kitamura, M., Kitamura, A., Mitarai, T., Maruyama, N., Nagasawa, R., Kawamura, T., Yoshida, H., Takahashi, T., and Sakai, O.: Gene expression of metalloproteinase and its inhibitor in mesangial cells exposed to high glucose. Biochem. Biophys. Res. Commun., 185, 1048-1054 1992.
39. McLennan, S.V., Fisher, E.J., Yue, D.K., and Turtle, J.R.: High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy. Diabetes, 43, 1041-1045, 1994.
40. Kitsiou, P.V., Tzinia, A.K., Stetler-Stevenson, W.G., Michael, A.F., Fan, W.W., Zhou, B., and Tsilibary, E.C.: Glucose-induced changes in integrins and matrix-related functions in cultured human glomerular epithelial cells. Am. J. Physiol. Renal Physiol., 284, F671-F679, 2003.
41. Cheng, X.W., Kuzuya, M., Sasaki, T., Kanda, S., Tamaya-Mori, N., Koike, T., Maeda, K., Nishitani, E., and Iguchi, A.: Green tea catechins inhibit neointimal hyperplasia in a rat carotid arterial injury model by TIMP-2 overexpression. Cardiovasc. Res., 62, 594-602, 2004.
42. Goldberg, G.I., Marmer, B.L., Grant, G.A., Eisen, A.Z., Wilhelm, S., and He, C.S.: Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. USA., 86, 8207-8211, 1989.
43. Ward, R.V., Atkinson, S.J., Slocombe, P.M., Docherty, A.J., Reynolds, J.J., and Murphy, G.: Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim. Biophys. Acta, 1079, 242-246, 1991.